AAPL   366.92 (+0.77%)
FB   234.64 (-1.23%)
GOOGL   1,484.96 (+2.98%)
AMZN   2,907.24 (+0.99%)
NVDA   388.07 (+1.80%)
CGC   16.49 (+0.12%)
TSLA   1,212.26 (+8.27%)
AMD   52.52 (-0.11%)
T   30.34 (+1.44%)
F   6.10 (+1.84%)
GILD   76.87 (+1.06%)
DIS   113.36 (+0.30%)
BAC   23.45 (+0.82%)
BA   182.19 (+1.04%)
AAPL   366.92 (+0.77%)
FB   234.64 (-1.23%)
GOOGL   1,484.96 (+2.98%)
AMZN   2,907.24 (+0.99%)
NVDA   388.07 (+1.80%)
CGC   16.49 (+0.12%)
TSLA   1,212.26 (+8.27%)
AMD   52.52 (-0.11%)
T   30.34 (+1.44%)
F   6.10 (+1.84%)
GILD   76.87 (+1.06%)
DIS   113.36 (+0.30%)
BAC   23.45 (+0.82%)
BA   182.19 (+1.04%)
AAPL   366.92 (+0.77%)
FB   234.64 (-1.23%)
GOOGL   1,484.96 (+2.98%)
AMZN   2,907.24 (+0.99%)
NVDA   388.07 (+1.80%)
CGC   16.49 (+0.12%)
TSLA   1,212.26 (+8.27%)
AMD   52.52 (-0.11%)
T   30.34 (+1.44%)
F   6.10 (+1.84%)
GILD   76.87 (+1.06%)
DIS   113.36 (+0.30%)
BAC   23.45 (+0.82%)
BA   182.19 (+1.04%)
AAPL   366.92 (+0.77%)
FB   234.64 (-1.23%)
GOOGL   1,484.96 (+2.98%)
AMZN   2,907.24 (+0.99%)
NVDA   388.07 (+1.80%)
CGC   16.49 (+0.12%)
TSLA   1,212.26 (+8.27%)
AMD   52.52 (-0.11%)
T   30.34 (+1.44%)
F   6.10 (+1.84%)
GILD   76.87 (+1.06%)
DIS   113.36 (+0.30%)
BAC   23.45 (+0.82%)
BA   182.19 (+1.04%)
Log in

OTCMKTS:OMBPOmni Bio Pharmaceutical Stock Price, Forecast & News

$0.03
+0.01 (+63.29 %)
(As of 06/25/2020)
Add
Compare
Today's Range
$0.03
Now: $0.03
$0.03
50-Day Range
$0.00
MA: $0.01
$0.04
52-Week Range
$0.00
Now: $0.03
$0.04
Volume100 shs
Average Volume2,893 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-22.95
Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company in the United States. It holds a license to use patent for the treatment of diabetes using plasma-derived alpha-1 antitrypsin (p-AAT), a protein that is purified from human blood. The company also holds licenses for the use of patents and patent applications covering the use of p-AAT in the treatment of cellular transplantation and graft rejection, radiation protection, bacterial and viral diseases, myocardial remodeling, and inflammatory bowel disease indications. In addition, it holds licenses for patent applications covering compositions of various Fc-AAT constructs. Omni Bio Pharmaceutical, Inc. was founded in 2006 and is headquartered in Fort Collins, Colorado.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.62 out of 5 stars


Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:OMBP
CUSIPN/A
Phone970-237-5178

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees1
Next Earnings DateN/A
OptionableNot Optionable

Receive OMBP News and Ratings via Email

Sign-up to receive the latest news and ratings for OMBP and its competitors with MarketBeat's FREE daily newsletter.

Omni Bio Pharmaceutical (OTCMKTS:OMBP) Frequently Asked Questions

How has Omni Bio Pharmaceutical's stock been impacted by COVID-19 (Coronavirus)?

Omni Bio Pharmaceutical's stock was trading at $0.0004 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, OMBP shares have increased by 6,350.0% and is now trading at $0.0258. View which stocks have been most impacted by Coronavirus.

Has Omni Bio Pharmaceutical been receiving favorable news coverage?

Media coverage about OMBP stock has been trending very negative this week, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Omni Bio Pharmaceutical earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave news stories about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news about Omni Bio Pharmaceutical.

Who are some of Omni Bio Pharmaceutical's key competitors?

What other stocks do shareholders of Omni Bio Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omni Bio Pharmaceutical investors own include Xenon Pharmaceuticals (XENE), aTyr Pharma (LIFE), Gemini (GKX), Flexion Therapeutics (FLXN), Biocept (BIOC) and Acorda Therapeutics (ACOR).

Who are Omni Bio Pharmaceutical's key executives?

Omni Bio Pharmaceutical's management team includes the following people:
  • Dr. Leland Shapiro M.D., Principal Investigator for Viral & Bacterial Disorders

What is Omni Bio Pharmaceutical's stock symbol?

Omni Bio Pharmaceutical trades on the OTCMKTS under the ticker symbol "OMBP."

How do I buy shares of Omni Bio Pharmaceutical?

Shares of OMBP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Omni Bio Pharmaceutical's stock price today?

One share of OMBP stock can currently be purchased for approximately $0.03.

What is Omni Bio Pharmaceutical's official website?

The official website for Omni Bio Pharmaceutical is www.omnibiopharma.com.

How can I contact Omni Bio Pharmaceutical?

Omni Bio Pharmaceutical's mailing address is 181 W BOARDWALK DRIVE SUITE 202, FORT COLLINS CO, 80525. The biopharmaceutical company can be reached via phone at 970-237-5178 or via email at [email protected]

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.